Race Oncology concludes successful Phase 1b/2 trial, secures R&D tax incentive

Retrieved on: 2024-10-21 00:45:34

Tags for this article:

Click the tags to see associated articles and topics

Race Oncology concludes successful Phase 1b/2 trial, secures R&D tax incentive. View article details on hiswai:

Excerpt

Race Oncology (ASX:RAC) has completed its Phase 1b/2 trial of bisantrene in combination with clofarabine and fludarabine for the treatment of ...

Article found on: www.finnewsnetwork.com.au